Amylin inhibits ovariectomy-induced bone loss in rats

Journal of Endocrinology

Volumn 165, Issue 3, 2000, Pages 663-668

  Horcajada Molteni, M N ^a   Davicco, M J ^a   Lebecque, P ^a   Coxam, V ^a   Young, A A ^b   Barlet, J P ^a  

^a CEMAGREF   (France)

^b AMYLIN PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; CALCIUM; DEOXYPYRIDINOLINE; OSTEOCALCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE DENSITY; CALCIUM BONE LEVEL; CANCELLOUS BONE; CONTROLLED STUDY; ESTROGEN DEFICIENCY; FEMALE; FEMUR; METAPHYSIS; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; RAT; TRABECULAR BONE;

EID: 0034093964     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1650663     Document Type: Article

References (32)

1. 2+ mobilization and cell retraction. Journal of Endocrinology 136 7-15.
2. Beaumont K, Kenney MA, Young AA & Rink TJ 1993 High affinity amylin binding sites in rat brain. Molecular Pharmacology 44 493-497.
3. Bone H, Hurley M, Goldstein H, Fineman M & Kolterman O 1999 Effects of administration of pramlintide for 12 months on bone metabolism markers in people with type 1 diabetes. Endocrine Society 81st Annual Meeting: Programs and Abstracts, p. 447.
4. Christopoulos G, Perry KJ, Morfis M, Tilakartatne N, Gao Y, Fraser NJ, Main MJ, Foord SM & Sexton P 1999 Multiple amylin receptors arise from receptor activity modifying protein interaction with the calcitonin receptor gene product. Molecular Pharmacology 56 235-242.
5. Cook JGH 1975 Factors influencing the assay of creatinine. Annals of Clinical Chemistry 12 219-232.
6. Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB & Reid KBM 1987 Purification and characterization of a peptide from amyloidrich pancreases of type 2 diabetic patients. PNAS 84 8628-8632.
7. Cornish J, Callon KE, Cooper GJ & Reid IR 1995 Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice. Biochemical and Biophysical Research Communications 207 133-139.
8. Cornish J, Callon KE, King AR, Cooper GJS & Reid IR 1998a Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice. American Journal of Physiology 275 E694-E699.
9. Cornish J, Callon KE, Lin CQX, Xiao CL, Mulvey TB, Coy DH, Cooper GJS & Reid IR 1998b Dissociation of the effects of amylin on osteoblast proliferation and bone resorption. American Journal of Physiology 274 E827-E833.
10. Datta HK, Zaïdi M, Wimalawansa SKJ, Ghatei MA, Beacham JL, Bloom SR & MacIntyre I 1989 IN vivo and in vitro effects of amylin and amylin-amide on calcium metabolism in the rat and the rabbit. Biochemical and Biophysical Research Communications 162 876-881.
11. Dempster DW & Lindsay R 1993 Pathogenesis of osteoporosis. Lancet i 797-801.
12. Horowitz MC 1993 Cytokines and estrogen in bone: anti-osteoporotic effects. Science 260 626-627.
13. Kalu DN 1991 The ovariectomized rat model of postmenopausal osteoporosis. Bone and Mineral 15 175-191.
14. MacIntyre I 1989 Amylinamide, bone conservation, and pancreatic β cells. Lancet ii 1026-1027.
15. MacLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Solari R, Lee MG & Foord SM 1998 RAMI's regulate the transport and ligand specificity of the calcitonin-like receptor. Nature 393 333-336.
16. Muff R, Born W & Fischer JA 1995 Calcitonin, calcitonin generelated peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions. European Journal of Endocrinology 133 17-20.
17. Ogawa A, Harris V, McCorkle SK, Unger RH & Luskey KL 1990 Amylin secretion from the rat pancreas and its selective loss after streptozotocin treatment. Journal of Clinical Investigation 85 973-976.
18. Oursler MJ, Osdoby P, Pifferven J, Riggs BL & Spelsberg TC 1991 Avian osteoclasts as estrogen target cells. PNAS 88 6613-6617.
19. Oursler MJ, Pederson L, Fitzpatrick L, Riggs BL & Spelsberg TC 1994 Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells. PNAS 91 5227-5231.
20. Pacifici R 1998 Editorial: cytokines, estrogen and postmenopausal osteoporosis - the second decade. Endocrinology 139 2659-2661.
21. Pastoureau P, Chomel A & Bonnet J 1995 Specific evaluation of localized bone mass and bone loss in the rat using dual energy X-ray absorptiometry subregional analysis. Osteoporosis International 5 143-149.
22. Robins SP 1994 Biochemical markers for assessing skeletal growth. European Journal of Clinical Nutrition 48 S199-S209.
23. Romero DF, Bryer HP, Rucinski B, Isserow JA, Buchinsky FJ, Cvetovic M, Liu CC & Epstein S 1995 Amylin increases bone volume but cannot ameliorate diabetic osteopenia. Calcified Tissue International 56 54-61.
24. Salomon CD 1971 Osteoporosis following calcium deficiency in rats. Calcified Tissue International 8 320-333.
25. Sissons HA, Kelman GI & Marotti G 1984 Mechanisms of bone resorption in calcium-deficient rats. Calcified Tissue International 36 711-721.
26. Turner CH & Burr CB 1993 Basic mechanical measurements of bone: a tutorial. Bone 14 595-608.
27. Van Daele PLA, Stolk RP, Burger H, Algra D, Grobbee DE, Hofman A, Birkenhäger JC & Pols HAP 1995 Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam study. Annals of Internal Medicine 122 409-414.
28. Wronski TJ & Yen CF 1991 The ovanectomized rat as a model for postmenopausal bone loss. Cells and Materials (Suppl 1) 69-74.
29. Young AA 1997 Amylin's physiology and its role in diabetes. Current Opinions in Endocrinology and Diabetes 4 282-290.
30. Young AA, Pittner R, Gedulin B, Vine W & Rink T 1995 Amylin regulation of carbohydrate metabolism. Biochemical Society Transactions 23 325-331.
31. Young AA, Vine W, Gedulin BR, Pittner R, Janes S, Gaeta LSL, Percy A, Moore CX, Koda JE & Rink TJ 1996 Preclinical pharmacology of pramlintide in the rat: comparisons wich human and rat amylin. Drug Development Research 37 231-248.
32. Zaïdi M, Shankar VS, Huang CLH, Pazianas M & Bloom SR 1993 Amylin in bone conservation: current evidence and hypothetical considerations. Trends in Endocrinology and Metabolism 4 255-259.